Blood GlucoseNCT06568497
Dairy and Vegan Cheese: Effect on Satiety and Blood Glucose
A study testing Food in people with Blood Glucose and Satiety Response, run by Mount Saint Vincent University at 1 site in Canada.
Trial summary
The project will consist of two studies. One study will explore the satiating properties of dairy cheese and its dairy-free substitute when consumed ad libidum, and another study will investigate their effects on postprandial glycemia. Both studies will involve healthy young adults. Read more about this study
- Who is it for?
- Ages 19 to 35 yearsHealthy volunteers can take part
- Conditions the study is for
- Blood Glucose, Satiety Response
- What is being tested?
- Food
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 52 participants
- Where
- 1 siteCanada
- Study dates
- 4 Aug 2024to 3 Oct 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 to 35 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Young healthy adults
Who cannot join
- Breakfast skipper
- Smoker (including e-cigarettes) / cannabis consumer
- Be underweight, overweight or obese
- Have chronic diseases, including diabetes
- Taking certain medication
- Have lactose intolerance, food allergies or gastrointestinal disorders (e.g., irritable bowel syndrome, or others).
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Sensory, Satiating and Glycaemic Characteristics of Cheese and Non-dairy Alternative Products to Cheese
The project will consist of two studies. One study will explore the satiating properties of dairy cheese and its dairy-free substitute when consumed ad libidum, and another study will investigate their effects on postprandial glycemia. Both studies will involve healthy young adults. The secondary outcomes of these studies will be food sensory characteristics, diet-induced thermogenesis, subjective feeling of fatigue and energy, gastrointestinal comfort level, and food intake. The proposed project results will help to better understand the health properties of the cheese and its dairy-free substitute.
- Conditions
- Blood Glucose, Satiety Response
- Being tested
- Food
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
FoodOther
Food
| Study group | Role | What they receive |
|---|---|---|
| Dairy | Experimental | A food containing dairy cheese Receives: Other: Food |
| Non-Dairy | Experimental | A food containing vegan alternative to cheese Receives: Other: Food |
| Conrtol | Experimental | A control treatment in the form of food Receives: Other: Food |
What is being measured
The primary outcome is the main question the study is designed to answer.
Blood glucose
The concentrations of blood glucose
Measured: 0-120 minutes
Insulin
The concentrations of insulin
Measured: 0-120 minutes
Satiety
The components of average subjective appetite including desire to eat, hunger, fullness, and a prospective food consumption measured with 100mm visual analogue scales.
Measured: 0-120 minutes
Food intake
Energy intake with an ad libitum meal at 120 minutes
Measured: 0 minutes, 120 minutes
Secondary outcomes (4)
Energy and Fatigue
Subjective perception of feeling energetic and fatigue
Measured: 0-120 minutes
Gastrointestinal comfort
The subjective feeling of wellness and gastrointestinal discomfort parameters including the feeling of nausea, stomach cramps, flatulency, diarrhea and a subjective feeling of wellness, each measured with 100mm visual analogue scales.
Measured: 0-120 minutes
Diet-induced thermogenesis
Indirect calorimetry
Measured: 0-120 minutes
Sensory characteristics
The perception of pleasantness of the treatments (0 minutes) and a test meal (at 120 minutes) will be measured with 9-point hedonic and 100mm visual analogue scales.
Measured: 0 minutes, 120 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Aug 2024
- Study start4 Aug 2024
- Primary completion3 Aug 2025
- Study completion3 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Blood GlucoseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 52 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mount Saint Vincent University
- Sponsor type
- University, hospital or other
- Collaborators
- Dairy Farmers of Canada
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06568497
- Sponsor's protocol ID
- 2023-147
- Status last verified
- Oct 2026
- First submitted
- 1 Aug 2024
- Last updated
- 9 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sensory, Satiating and Glycaemic Characteristics of Cheese and Non-dairy Alternative Products to Cheese
- ClinicalTrials.gov ID
- NCT06568497
- Acronym / sponsor ID
- 2023-147
- Conditions
- Blood Glucose, Satiety Response
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 52 participants (actual)
- Lead sponsor
- Mount Saint Vincent UniversityUniversity, hospital or other
- Collaborators
- Dairy Farmers of Canada
- Study start
- 4 Aug 2024 (actual)
- Primary completion
- 3 Aug 2025 (actual)
- Study completion
- 3 Oct 2025 (actual)
- First posted
- 23 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The project will consist of two studies. One study will explore the satiating properties of dairy cheese and its dairy-free substitute when consumed ad libidum, and another study will investigate their effects on postprandial glycemia. Both studies will involve healthy young adults. The secondary outcomes of these studies will be food sensory characteristics, diet-induced thermogenesis, subjective feeling of fatigue and energy, gastrointestinal comfort level, and food intake. The proposed project results will help to better understand the health properties of the cheese and its dairy-free substitute.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Dairy | Experimental | Other: FoodA food containing dairy cheese |
| Non-Dairy | Experimental | Other: FoodA food containing vegan alternative to cheese |
| Conrtol | Experimental | Other: FoodA control treatment in the form of food |
Who may qualify
- Ages
- 19 to 35 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Young healthy adults
Key exclusion criteria (6 listed)
- Breakfast skipper
- Smoker (including e-cigarettes) / cannabis consumer
- Be underweight, overweight or obese
- Have chronic diseases, including diabetes
- Taking certain medication
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| FoodFood | Other | Conrtol, Dairy, Non-Dairy |
Primary outcome
Blood glucose
Time frame: 0-120 minutes
The concentrations of blood glucose
Insulin
Time frame: 0-120 minutes
The concentrations of insulin
Satiety
Time frame: 0-120 minutes
The components of average subjective appetite including desire to eat, hunger, fullness, and a prospective food consumption measured with 100mm visual analogue scales.
Food intake
Time frame: 0 minutes, 120 minutes
Energy intake with an ad libitum meal at 120 minutes
4 secondary outcomes
Energy and Fatigue
Time frame: 0-120 minutes
Gastrointestinal comfort
Time frame: 0-120 minutes
Diet-induced thermogenesis
Time frame: 0-120 minutes
Sensory characteristics
Time frame: 0 minutes, 120 minutes
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Blood Glucose
RecruitingObservational study
Glucose Levels and Outcomes in Women - Mid Pregnancy
Pregnancy
Enrolling by invitationEarly Phase 1
Truway Diagnostic Tools in Primary Care
Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Not yet recruiting
A Nurse-Led Digital Coaching Program to Improve Blood Sugar Control in Adults With Type 2 Diabetes
Type 2 Diabetes Mellitus
Not yet recruiting
A Study to Lower Blood Pressure One Year After Childbirth in Women Who Had Preeclampsia
Adverse Pregnancy Outcomes, Cardiovascular Diseases
Not yet recruitingEarly Phase 1
Human Cerebrovascular Blood Flow and Sex Differences in Metabolic Syndrome
Metabolic Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Food in people with Blood Glucose and Satiety Response, run by Mount Saint Vincent University at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Blood glucose (time frame: 0-120 minutes). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.